Yellow Eyes (Jaundice): Causes, Symptoms, and When to Seek Help

Yellow eyes are a visible sign of jaundice: an accumulation of bilirubin in the blood above 3 mg/dL that stains the sclera (the white of the eye) yellow or orange. According to NCBI StatPearls, scleral icterus becomes visible when serum bilirubin exceeds 3 mg/dL, while normal levels range from 0.1 to 1.2 mg/dL per NIH MedlinePlus. The most common underlying causes are liver disease (hepatitis, cirrhosis), bile duct obstruction (gallstones, tumors), and blood disorders (hemolytic anemia). Yellow eyes should never be dismissed as minor: per the Cleveland Clinic, jaundice always requires prompt medical evaluation to identify the underlying cause. Seek emergency care immediately if yellowing is accompanied by fever above 38°C (100.4°F), severe abdominal pain, confusion, or signs of bleeding.

What Yellow Eyes Are and Why They Occur

Yellow eyes are a visible manifestation of jaundice, a condition in which the sclera, skin, and mucous membranes take on a yellow or orange tint. To understand the underlying eye anatomy involved, the sclera is the tough outer coat of the eyeball, and it is particularly susceptible to bilirubin staining because of the high collagen content in the tissue, which binds bilirubin avidly.

According to NIH MedlinePlus, jaundice occurs when there is too much bilirubin in the blood. Bilirubin is a yellow pigment produced naturally when the body breaks down old red blood cells. Under normal conditions, the liver conjugates (processes) bilirubin and excretes it through bile into the intestine.

How Bilirubin Causes the Yellow Coloration

Jaundice becomes visible when serum bilirubin exceeds 3 mg/dL, compared to a normal range of 0.1 to 1.2 mg/dL per NIH MedlinePlus. When the liver cannot process bilirubin fast enough, when the bile ducts are blocked, or when red blood cells are destroyed too rapidly, bilirubin accumulates in the blood and deposits in tissues, producing the characteristic yellow discoloration.

The sclera is often the first place jaundice becomes visible because it has a high collagen concentration and a rich blood supply close to the surface.

Main Causes of Yellow Eyes

Jaundice: The Most Common Cause

Jaundice results from bilirubin accumulation through three distinct mechanisms:

1. Pre-hepatic jaundice: Excessive production of bilirubin from accelerated red blood cell destruction (hemolysis)
2. Hepatic jaundice: Liver dysfunction that impairs bilirubin metabolism
3. Post-hepatic (obstructive) jaundice: Bile duct blockage that prevents bilirubin excretion

Liver Disease

Viral, Alcoholic, and Autoimmune Hepatitis

Hepatitis in any form compromises the liver’s ability to conjugate and excrete bilirubin. According to WHO updated hepatitis B guidelines, more than 250 million people live with chronic hepatitis B globally, and jaundice is a common symptom during acute flares. Viral hepatitis A, B, and C, alcoholic hepatitis, and autoimmune hepatitis all produce the same end result: impaired bilirubin processing and visible scleral icterus.

Cirrhosis

Cirrhosis replaces functional liver tissue with scar tissue, progressively impairing all liver functions. Research published in NCBI on liver cirrhosis reports that 10-year survival for compensated cirrhosis is approximately 47%, falling to 16% after a decompensation event such as the onset of jaundice. Once jaundice appears in cirrhosis, it indicates significant functional impairment.

Liver Cancer

Hepatocellular carcinoma and bile duct cancers (cholangiocarcinoma) can obstruct biliary drainage from within or outside the liver, producing obstructive jaundice as a sign of advanced disease.

Blood Disorders

Hemolytic Anemia

Conditions that cause abnormally rapid destruction of red blood cells flood the liver with more bilirubin than it can process. According to Haematologica (European Hematology Association), first-line therapy with corticosteroids is expected to provide a response in 70-85% of patients with warm autoimmune hemolytic anemia, though only around one in three maintain long-term remission after discontinuation. Causes range from autoimmune disease to genetic conditions (sickle cell disease, hereditary spherocytosis) and infections.

Bile Duct Obstruction

Gallstones

Gallstones lodged in the common bile duct block bile flow from the liver to the intestine. Bilirubin backs up into the bloodstream, producing post-hepatic jaundice. This type is often accompanied by colicky right upper quadrant pain and is frequently treatable with endoscopic or surgical intervention.

Tumors and Strictures

Pancreatic cancer is a particularly common cause of obstructive jaundice: the head of the pancreas lies adjacent to the common bile duct, and tumors in this location compress or invade the duct. Other causes include cholangiocarcinoma, lymph node enlargement from metastases, and benign bile duct strictures.

Malaria

In malaria-endemic regions, the parasite Plasmodium destroys red blood cells at a rapid rate, producing a hemolytic pre-hepatic jaundice. According to the WHO malaria fact sheet, malaria caused an estimated 263 million cases globally in 2023. Travelers returning from endemic regions who develop yellow eyes should be evaluated for malaria as part of the differential diagnosis.

Pinguecula (Localized Yellow Spot, Not True Jaundice)

A pinguecula is a small, yellowish or whitish growth on the conjunctiva (the membrane covering the white of the eye). Unlike jaundice, it is a localized benign deposit of protein and calcium, not a systemic bilirubin elevation. It produces a focal yellow spot near the corneal edge without any systemic symptoms. A clinician can distinguish it from jaundice immediately by location and context.

What Opticians and Ophthalmologists Spot Before the Patient Does

Eye care professionals occupy a unique early-warning position in the jaundice detection chain. A patient may walk in for a routine frame adjustment or annual refraction with no awareness that anything is systemically wrong, and the optician or ophthalmologist at the dispensing counter or slit lamp will be the first person to notice.

Counter lighting catches subtle icterus before mirror awareness. The intense, close-range lighting at an optical dispensing counter tends to illuminate the bulbar conjunctiva more consistently than a bathroom mirror under home lighting. In practice, subtle bilirubin staining that a patient has attributed to tiredness or screen time looks distinctly yellow-orange under the counter lamp. This is not a clinical examination, but it is often where the conversation begins: “Has anyone mentioned your eyes look a little yellow?” That question, asked by an optician during a frame fitting, has triggered more than a few urgent GP referrals.

At the slit lamp, early hyperbilirubinemia leaves a clear signature. Per NCBI, conjunctival icterus becomes apparent when bilirubin levels exceed 2 mg/dL, before the 3 mg/dL threshold at which most patients notice yellowing themselves. Under slit lamp biomicroscopy, the diffuse yellow-amber staining of the bulbar conjunctiva is visible at this earlier threshold, particularly in the lower bulbar region when the patient looks up. In patients with darker skin, the conjunctiva may be the only visible jaundice sign on external examination.

The pinguecula differential is a daily optometry task. Both conditions produce yellow coloration at the limbus, but they are clinically distinct:

Per NCBI StatPearls on pinguecula, a pinguecula “appears as a grey white-yellow mass on the bulbar conjunctiva” with predilection for the nasal conjunctiva at the 3 or 9 o’clock position. The nodular, raised morphology and focal location distinguish it immediately from the smooth, diffuse staining of icterus.

The carotenoderma exception. A third yellow-eye mimic worth knowing: carotenemia from excessive dietary beta-carotene can turn the skin and even the conjunctiva faintly yellow but characteristically spares the sclera, producing yellowing in the skin folds and palms rather than in the whites of the eye. This scleral sparing is the key distinguishing feature when a patient arrives with yellow-tinted skin but a normal scleral exam.

When an optician or ophthalmologist identifies probable scleral icterus, the appropriate next step is same-day referral to a primary care physician or emergency department, depending on whether systemic symptoms (fever, severe abdominal pain, confusion) are present.

Identifying Yellow Eyes: Symptoms and Warning Signs

Visual Recognition

Jaundice is identified by direct inspection of the sclera in natural light. Artificial lighting, especially fluorescent, distorts the apparent color. Under normal conditions the sclera appears white or faintly blue-white; bilirubin staining turns it yellow or orange. In systemic jaundice the coloration is symmetric. Natural daylight gives the most accurate assessment: ask the person to look up slightly while you examine the lower sclera.

Symptoms Associated with Jaundice

Yellow eyes from jaundice are rarely the only finding. The accompanying symptoms provide critical clues about the underlying cause:

Jaundice does not directly impair visual acuity: the yellowing stains the sclera but does not affect the cornea, lens, or retina in typical cases.

Emergency Symptoms

Seek emergency medical care immediately if yellow eyes appear alongside any of the following:

• Fever above 38°C (100.4°F)
• Severe pain in the right upper abdomen
• Confusion, excessive drowsiness, or disorientation (signs of hepatic encephalopathy)
• Persistent vomiting
• Signs of bleeding: dark tarry stools, blood in vomit, or easy bruising
• Rapidly worsening jaundice over hours or days

Light sensitivity (photophobia) occasionally accompanies acute hepatitis, particularly during the prodromal phase.

When to Seek Medical Attention

Situations Requiring Urgent Evaluation

The Cleveland Clinic recommends seeing a doctor immediately when you notice any yellowing of the eyes or skin, as jaundice can signal liver, blood, or gallbladder problems. The Mayo Clinic notes that jaundice in adults is almost always a symptom of an underlying condition requiring diagnosis, not a condition to manage expectantly.

Seek emergency care in the following situations:

1. Jaundice with fever and chills: May indicate cholangitis (bile duct infection), which can progress to septic shock within hours
2. Severe abdominal pain: Especially in the right upper quadrant or radiating to the back; may signal acute biliary obstruction or perforation
3. Altered mental status: Confusion, agitation, or excessive sleepiness can indicate hepatic encephalopathy, a life-threatening complication of liver failure
4. Bleeding signs: Coagulopathy from liver failure causes easy bruising and spontaneous bleeding

Scheduled (Non-Urgent) Appointments

Book a same-week (not emergency) medical appointment when:

• Mild yellowing of the eyes appears with no other symptoms
• Persistent fatigue occurs alongside darker-than-usual urine
• You have a family history of liver or blood disorders
• Regular alcohol use coincides with new changes in eye color

Diagnosing Yellow Eyes

Initial Clinical Assessment

A doctor will conduct a physical examination looking at:

• Degree of icterus in the sclera, skin, and mucous membranes
• Liver and spleen size and texture (abdominal palpation)
• Signs of chronic liver disease: spider angiomas, palmar erythema, ascites

An ophthalmologist can also identify early scleral icterus during routine eye examinations, sometimes before patients notice yellowing themselves. This is one reason regular eye exams carry value beyond vision correction.

Essential Lab Tests

Bilirubin Measurement

According to NIH MedlinePlus, normal bilirubin values are:

• Total bilirubin: 0.1 to 1.2 mg/dL (1.71 to 20.5 µmol/L)
• Direct (conjugated) bilirubin: less than 0.3 mg/dL (less than 5.1 µmol/L)

Jaundice becomes visible when total bilirubin exceeds 2.5 to 3 mg/dL. The ratio of direct to indirect bilirubin helps differentiate the cause: elevated indirect (unconjugated) bilirubin suggests hemolysis or liver cell dysfunction; elevated direct (conjugated) bilirubin points toward bile duct obstruction.

Liver Function Panel

• Transaminases (AST, ALT): Elevated in hepatocellular injury (hepatitis, drug toxicity)
• Alkaline phosphatase and GGT: Elevated in cholestasis (bile duct obstruction)
• Albumin and prothrombin time: Assess liver synthetic function; abnormal values indicate more severe impairment

Complete Blood Count (CBC)

Identifies hemolytic anemia through:

• Decreased hemoglobin
• Elevated reticulocytes (young red blood cells, indicating accelerated production)
• Abnormal red blood cell morphology on peripheral smear

Imaging Studies

Abdominal ultrasound: The standard first imaging test, evaluating liver size and texture, gallstones, bile duct dilation, and hepatic or pancreatic masses.

CT scan or MRI: Used when ultrasound is inconclusive or when tumor characterization is needed.

Magnetic resonance cholangiopancreatography (MRCP): Provides detailed imaging of the bile ducts without invasive procedures, useful for diagnosing stones or strictures.

Treatment Based on the Underlying Cause

There is no treatment that “whitens” the eyes directly. The yellow color resolves only when bilirubin levels fall, which happens when the underlying cause is treated. The specific treatment depends entirely on diagnosis.

Treating Liver Disease

Acute Viral Hepatitis

If jaundice results from acute viral hepatitis, it typically resolves as the liver recovers. Supportive management includes:

• Adequate rest during the acute phase
• Oral hydration
• Balanced diet without specific fat restriction
• Complete abstinence from alcohol
• Avoiding hepatotoxic medications
• Regular monitoring of liver function tests

Per the WHO hepatitis A fact sheet, “there is no specific antiviral treatment for hepatitis A” and “the management of hepatitis A focuses on supportive care to relieve symptoms and ensure adequate hydration and nutrition.” Similarly, per the WHO hepatitis E fact sheet, “there is no specific antiviral treatment capable of altering the course of acute hepatitis E,” and the infection is “usually self-limiting.” Hepatitis B and C, however, may require antiviral therapy.

Chronic Hepatitis and Cirrhosis

• Antivirals: Direct-acting antivirals for hepatitis B and C
• Corticosteroids and immunosuppressants: For autoimmune hepatitis
• Complication management: Diuretics for ascites, lactulose for encephalopathy, beta-blockers for portal hypertension
• Liver transplant: For end-stage liver disease when other options are exhausted

Treating Bile Duct Obstruction

Gallstones

• Endoscopic retrograde cholangiopancreatography (ERCP): Endoscopic removal of common bile duct stones
• Cholecystectomy: Laparoscopic gallbladder removal to prevent recurrence
• Biliary drainage: For complete obstruction when endoscopic removal is not immediately possible

Tumors and Strictures

• Surgery: Resection where technically feasible
• Biliary stents: Metal or plastic stents to maintain bile duct patency
• Chemotherapy and radiotherapy: For malignant causes

Treating Blood Disorders

For hemolytic anemia, treatment options include:

• Corticosteroids: First-line for autoimmune hemolytic anemia; effective in 70-85% of patients per Haematologica
• Intravenous immunoglobulin: For severe or refractory cases
• Immunosuppressants: Rituximab, azathioprine for steroid-dependent disease
• Folic acid supplementation: Supports new red blood cell production
• Blood transfusion: For life-threatening anemia
• Splenectomy: In selected refractory cases

Phototherapy (Neonates)

For neonatal jaundice, high-intensity LED phototherapy is the standard treatment. Blue-spectrum light at approximately 460 to 490 nm converts unconjugated bilirubin in the skin into water-soluble isomers that the body can excrete without liver conjugation. Per NICE guidance on neonatal jaundice (CG98), phototherapy should start promptly when bilirubin levels approach treatment thresholds based on gestational age and postnatal hours.

The 2022 AAP clinical practice guideline updated neonatal phototherapy thresholds significantly from the 2004 guideline, introducing age- and risk-stratified nomograms that account for gestational age, postnatal hours, and hyperbilirubinemia neurotoxicity risk factors. Under the current 2022 framework, the earlier 25 mg/dL figure cited in older literature now falls within exchange-transfusion territory rather than the phototherapy initiation threshold, which is individualized and generally lower. Parents should always consult a pediatrician: thresholds vary considerably by gestational age and clinical risk.

Supportive Medications

• Ursodeoxycholic acid: Improves bile flow in certain cholestatic conditions
• Antihistamines or cholestyramine: For bile salt-related itching
• Fat-soluble vitamins (A, D, E, K): For malabsorption caused by prolonged cholestasis

Prognosis and Recovery

Recovery Timeline

How quickly the sclera returns to normal depends on the cause and how promptly treatment begins:

Factors Affecting Prognosis

According to research on liver cirrhosis from NCBI:

• Severity of liver dysfunction: Measured by the Child-Pugh score and the MELD score. A MELD score above 15 in a patient with jaundice typically warrants consideration for transplant listing.
• Cause of jaundice: Obstructive causes from benign stones carry a better prognosis than malignant obstruction or decompensated cirrhosis.
• Presence of complications: Infections, bleeding, or encephalopathy worsen outcomes significantly.
• Treatment adherence: Consistent follow-up is critical for chronic liver and blood conditions.

Post-Treatment Monitoring

After jaundice resolves:

• Periodic liver function tests
• Follow-up with a hepatologist or gastroenterologist
• Hepatitis A and B vaccination if not previously immunized
• Lifestyle adjustments per the diagnosed condition (alcohol cessation, weight management)

Preventing Jaundice and Yellow Eyes

Protecting Liver Health

Vaccination

Following WHO’s 2024 hepatitis B guidelines, the hepatitis B vaccine is one of the most effective tools for preventing liver disease leading to jaundice. WHO has set a target of reducing new hepatitis infections and deaths by 90% and 65%, respectively, by 2030.

Recommended vaccines:

• Hepatitis A (two doses)
• Hepatitis B (three-dose primary series, with options for accelerated schedules)
• Combined hepatitis A + B vaccine

Alcohol Moderation

Alcohol is among the leading causes of preventable liver disease. Safe limits are up to one standard drink per day for women and two per day for men, with two or three alcohol-free days per week. Any established liver disease warrants complete abstinence.

Responsible Medication Use

• Avoid self-medicating with analgesics or anti-inflammatories beyond recommended doses
• Paracetamol (acetaminophen) is hepatotoxic in excess: do not exceed 3 to 4 grams per day; lower thresholds apply if you drink regularly or have liver disease
• Inform your doctor of all medications and supplements, including herbal products

Preventing Blood Disorders

• Annual blood count if family history includes hemolytic anemia or hereditary hemoglobin disorders
• Regular follow-up for known autoimmune conditions
• Avoid hemolysis triggers in susceptible individuals (certain medications and fava beans in G6PD deficiency)

Preventing Gallstones

• Maintain a healthy body weight; obesity significantly increases gallstone risk
• Avoid very-low-calorie diets or rapid weight loss (accelerates cholesterol stone formation)
• Eat a diet rich in fiber and low in saturated fat
• Regular physical activity
• Adequate hydration

Safe Practice

Per the WHO hepatitis prevention guidelines, essential prevention services include:

• Use only sterile instruments for piercings, tattoos, and medical or dental procedures
• Blood safety: receive transfusions only in certified medical facilities
• Prevention of mother-to-child transmission: antiviral prophylaxis for pregnant people with hepatitis B
• Harm reduction: needle exchange programs for people who inject drugs

Routine Check-Ups

Regular check-ups should include:

• Complete blood count (annually)
• Liver function tests (AST, ALT, bilirubin) annually, or more often if risk factors exist
• Abdominal ultrasound if liver or gallbladder disease risk factors are present

An ophthalmologist can also identify early scleral changes during routine eye exams, including subtle early-stage icterus, before patients are aware of systemic illness.

Frequently Asked Questions About Yellow Eyes

The Importance of Early Diagnosis

Yellow eyes are a visible warning that something is wrong systemically, not just in the eye. Bilirubin accumulates because the liver cannot process it fast enough, the bile ducts are blocked, or red blood cells are destroyed too rapidly. All three mechanisms have treatable causes, and outcomes are significantly better when treatment begins early.

Key points to remember:

1. Seek medical attention immediately when you notice yellowing of the eyes, particularly with fever, abdominal pain, or confusion
2. Early diagnosis substantially improves outcomes across virtually all causes of jaundice
3. There is no single “cure” for yellow eyes: the yellow color resolves only when the underlying condition is treated
4. Prevention is possible through hepatitis vaccination, moderate alcohol use, responsible medication habits, and routine blood and liver check-ups
5. Regular eye examinations allow eye care professionals to identify early scleral icterus before patients notice systemic illness

Jaundice is a symptom, not a diagnosis. Identifying the cause promptly determines whether recovery is complete.

This article is intended for general informational purposes only and does not constitute medical advice. If you notice yellowing of the eyes or skin, consult a qualified healthcare professional for a proper evaluation and diagnosis.

Saulo Garcia

I am a seasoned software engineer with over two decades of experience and a deep-rooted background in the optical industry, thanks to a family business. Driven by a passion for developing impactful software solutions, I pride myself on being a dedicated problem solver who strives to transform challenges into opportunities for innovation.